-
Mashup Score: 1Pharmalittle: We're reading about MDMA for PTSD, a CRISPR treatment for blindness, and more - 13 day(s) ago
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Pharmalittle: We're reading about FTC reviewing Novo-Catalent deal, Amneal opioid settlement, and more - 14 day(s) ago
The FTC wants more information on a $16.5 million deal in which Novo Nordisk’s parent company would purchase Catalent, a contract drug manufacturer.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2Pharmalittle: We're reading about an Amgen obesity drug, a Senate bill on shortages, and more - 17 day(s) ago
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
The move by the California Supreme Court to review the case is seen as “very important,” according Evercore ISI analyst Umer Raffat.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
The move by the California Supreme Court to review the case is seen as “very important,” according Evercore ISI analyst Umer Raffat.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Pharmalittle: We're reading about Wegovy and Ozempic sales, rising pharma layoffs, and more - 18 day(s) ago
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Pharmalittle: We're reading about FTC fighting 'junk' patents, Pfizer direct-to-consumer plans, and more - 19 day(s) ago
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0'Skinny labels' on generic medicines saved Medicare $15 billion over a recent six-year period - 19 day(s) ago
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3
“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs,” said FTC Chair Lina Khan.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Pharmalittle: We're reading about a Medicare price-negotiation ruling, pharma's slipping reputation, and more - 20 day(s) ago
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about MDMA for PTSD, a CRISPR treatment for blindness & more news.. https://t.co/H6yl7Twm2V #pharma #MDMA #PTSD #abortion #mifepristone #FDA $PFE $EDIT